SG47384A1 - Cdna sequence of dengue virus serotype 1 (singapore strain) - Google Patents

Cdna sequence of dengue virus serotype 1 (singapore strain)

Info

Publication number
SG47384A1
SG47384A1 SG1996000334A SG1996000334A SG47384A1 SG 47384 A1 SG47384 A1 SG 47384A1 SG 1996000334 A SG1996000334 A SG 1996000334A SG 1996000334 A SG1996000334 A SG 1996000334A SG 47384 A1 SG47384 A1 SG 47384A1
Authority
SG
Singapore
Prior art keywords
den1
pct
cdna sequence
dengue virus
virus serotype
Prior art date
Application number
SG1996000334A
Other languages
English (en)
Inventor
Jianlin Fu
Boon-Huan Tan
Yin-Hwee Tan
Eu-Hian Yap
Yow-Cheong Chan
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Publication of SG47384A1 publication Critical patent/SG47384A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24121Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
SG1996000334A 1992-04-29 1993-04-28 Cdna sequence of dengue virus serotype 1 (singapore strain) SG47384A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209243A GB9209243D0 (en) 1992-04-29 1992-04-29 Dengue virus

Publications (1)

Publication Number Publication Date
SG47384A1 true SG47384A1 (en) 1998-04-17

Family

ID=10714729

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996000334A SG47384A1 (en) 1992-04-29 1993-04-28 Cdna sequence of dengue virus serotype 1 (singapore strain)

Country Status (11)

Country Link
US (1) US6017535A (fr)
EP (1) EP0638122B1 (fr)
KR (1) KR950701684A (fr)
AT (1) ATE161048T1 (fr)
AU (1) AU679179B2 (fr)
CA (1) CA2134666A1 (fr)
DE (1) DE69315689T2 (fr)
GB (1) GB9209243D0 (fr)
MY (1) MY110899A (fr)
SG (1) SG47384A1 (fr)
WO (1) WO1993022440A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676936B1 (en) 1988-07-14 2004-01-13 The United States Of America As Represented By The Department Of Health And Human Services. Chimeric and/or growth-restricted flaviviruses
AU6093296A (en) * 1995-06-07 1996-12-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Infectious dengue 2 virus pdk-53 as quadravalent vaccine
DE19613253A1 (de) * 1996-04-02 1997-10-09 Immuno Gmbh Technik zum Nachweis von Infektionen mit dem TBE-Virus und anderen Flaviviren
FR2767324B1 (fr) * 1997-08-14 2001-04-06 Pasteur Institut Utilisation de proteines d'enveloppe recombinantes pour le diagnostic du virus de la dengue
US5968732A (en) * 1997-12-31 1999-10-19 Akzo Nobel, N.V. Isothermal transcription based assay for the detection and genotyping of dengue virus
FR2794865B1 (fr) 1999-06-09 2003-04-18 Pasteur Institut Methode de detection precoce des flavivirus et ses applications
US6855521B2 (en) * 1999-12-01 2005-02-15 The United States Of America As Represented By The Secretary Of The Navy Serotype and dengue group specific flurogenic probe based PCR (TaqMan) assays against the respective C and NS5 genomic and 3′ non-coding regions of dengue virus
US20020164349A1 (en) * 2000-10-04 2002-11-07 Weiner David B. Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
US20040005457A1 (en) * 2002-07-03 2004-01-08 Kimberly-Clark Worldwide, Inc. Methods of improving the softness of fibers and nonwoven webs and fibers and nonwoven webs having improved softness
KR100890885B1 (ko) * 2003-03-31 2009-03-31 에프. 호프만-라 로슈 아게 일본 뇌염 바이러스 혈청군의 구성원을 포함하는, 특정플라비바이러스 검출용 조성물 및 방법
CA2770888C (fr) 2009-08-31 2020-04-14 Gen-Probe Incorporated Essai du virus de la dengue
US10308689B2 (en) * 2010-06-24 2019-06-04 La Jolla Institute For Allergy And Immunology Dengue virus (DV) polypeptide sequences, T cell epitopes and methods and uses thereof
KR20130031909A (ko) * 2010-07-29 2013-03-29 빅텍 프라이빗 리미티드 뎅기열 검출을 위한 프로브 및 프라이머
EP2707496A1 (fr) 2011-05-11 2014-03-19 Diagon Kft. Procédé de détermination rapide de virus à l'aide de diagnostics moléculaires basés sur des acides nucléiques, et trousse pour sa mise en oeuvre
WO2012159187A2 (fr) * 2011-05-26 2012-11-29 Universidade Federal Do Rio De Janeiro - Ufrj Peptides dérivés du virus de la dengue denv et méthodes pour inhiber la réplication du flavivirus

Also Published As

Publication number Publication date
KR950701684A (ko) 1995-04-28
ATE161048T1 (de) 1997-12-15
WO1993022440A1 (fr) 1993-11-11
MY110899A (en) 1999-06-30
EP0638122A1 (fr) 1995-02-15
AU679179B2 (en) 1997-06-26
US6017535A (en) 2000-01-25
EP0638122B1 (fr) 1997-12-10
DE69315689D1 (de) 1998-01-22
AU4257593A (en) 1993-11-29
DE69315689T2 (de) 1998-04-02
GB9209243D0 (en) 1992-06-17
CA2134666A1 (fr) 1993-11-11

Similar Documents

Publication Publication Date Title
SG47384A1 (en) Cdna sequence of dengue virus serotype 1 (singapore strain)
DE69430246T2 (de) Rekombinante tetc-fusionsprotein enthaltene impfstoffzusammensetzungen
ES2168258T3 (es) Vectores virales recombinantes que codifican para proteinas de papilomavirus humano.
HUP9801122A2 (hu) Osteoprotegerin
BR9809445A (pt) Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico.
IL134392A0 (en) Vaccine against hpv
IL136634A0 (en) Recombinant noda virus compositions and methods
ATE364083T1 (de) Immunogene zusammensetzungen gegen eine helicobacterinfektion, verwendung von polypeptiden in diesen zusammensetzungen und nukleinsäurendie besagte polypeptide kodieren
HUP0104750A2 (hu) OPG fúziósfehérje összetételek és eljárások
EP0602046A4 (fr) Detection des virus de l'immunodeficience chez les mammiferes.
GB9401987D0 (en) Modified nucleic acid
AU4826493A (en) Anti-feline immunodeficiency virus (fiv) vaccines
CA2089753A1 (fr) Fusions de genes d'interleukine-2 et de leucotoxine et leurs utilisations
DE68923006D1 (de) Fusionsproteine der untereinheit b von choleratoxin und eines heterologen antigens und dafür kodierende rekombinante nukleinsäure.
DE3879881D1 (de) Rekombinante hiv-2 polypeptide.
NO964874L (no) Fusjonsglykoprotein fra HCMV og HSV
ATE270333T1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
DE69130675T2 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
ZA907944B (en) Hiv related peptides
HUP9904137A2 (hu) Immunterápiás szerként hasznosítható polipeptidek és eljárások a polipeptidek előállítására
NZ334582A (en) Polyprotein construct of a papillomavirus
KR970006317A (ko) Hcv 코아 단백질의 융합단백질 및 이의 제조방법
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.